客户发表文献

论文在线提交

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

开始时间
页码: 60/356 每页显示数量
One ring closer to a closure: the crystal structure of the ES hydroxymethylbilane synthase intermediate
Authors: Helene J Bustad, Marthe S Christie, Mikko Laitaoja, Aasne K Aarsand, Aurora Martinez, Janne Jänis, Juha P Kallio
Journal: FEBS J
PubMed ID: 37863644
Doi: 10.1111/febs.16982
Vγ9+Vδ2+ T cell control of Listeria monocytogenes growth in infected epithelial cells requires butyrophilin 3A genes
Authors: Katrin Fischer, Michaela Bradlerova, Thomas Decker, Verena Supper
Journal: Sci Rep
PubMed ID: 37903831
Doi: 10.1038/s41598-023-45587-1
Structural and dynamical changes of the Streptococcus gordonii metalloregulatory ScaR protein induced by Mn ion binding
Authors: Katarina Radman, Zoe Jelić Matošević, Dijana Žilić, Ivo Crnolatac, Nikola Bregović, Marina Kveder, Ivo Piantanida, Pedro A Fernandes, Ivana Leščić Ašler, Branimir Bertoša
Journal: Int J Biol Macromol
PubMed ID: 37866578
Doi: 10.1016/j.ijbiomac.2023.127572
Adaptation of the late ISC pathway in the anaerobic mitochondrial organelles of Giardia intestinalis
Authors: Alžběta Motyčková, Luboš Voleman, Vladimíra Najdrová, Lenka Arbonová, Martin Benda, Vít Dohnálek, Natalia Janowicz, Ronald Malych, Róbert Šuťák, Thijs J G Ettema, Staffan Svärd, Courtney W Stairs, Pavel Doležal
Journal: PLoS Pathog
PubMed ID: 37792908
Doi: 10.1371/journal.ppat.1010773
The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection
Authors: Déborah Lécuyer, Roberta Nardacci, Désirée Tannous, Emie Gutierrez-Mateyron, Aurélia Deva Nathan, Frédéric Subra, Cristina Di Primio, Paola Quaranta, Vanessa Petit, Clémence Richetta, Ali Mostefa-Kara, Franca Del Nonno, Laura Falasca, Romain Marlin, Pauline Maisonnasse, Julia Delahousse, Juliette Pascaud, Eric Deprez, Marie Naigeon, Nathalie Chaput, Angelo Paci, Véronique Saada, David Ghez, Xavier Mariette, Mario Costa, Mauro Pistello, Awatef Allouch, Olivier Delelis, Mauro Piacentini, Roger Le Grand, Jean-Luc Perfettini
Journal: Front Immunol
PubMed ID: 37920468
Doi: 10.3389/fimmu.2023.1270081
A novel recombinant S-based subunit vaccine induces protective immunity against porcine deltacoronavirus challenge in piglets
Authors: Jizong Li, Shuqing Zhao, Baotai Zhang, Jin Huang, Qi Peng, Li Xiao, Xuesong Yuan, Rongli Guo, Jinzhu Zhou, Baochao Fan, Tao Xue, Xuejiao Zhu, Chuanmin Liu, Xing Zhu, Lili Ren, Bin Li
Journal: J Virol
PubMed ID: 37846983
Doi: 10.1128/jvi.00958-23
miR-19b-3p regulated by estrogen controls lipid synthesis through targeting MSMO1 and ELOVL5 in LMH cells
Authors: Qihui Jia, Yuzhu Cao, Mengmeng Zhang, Yuxin Xing, Tian Xia, Yulong Guo, Yaxin Yue, Xin Li, Xiaojun Liu, Yanhua Zhang, Donghua Li, Zhuanjian Li, Yadong Tian, Xiangtao Kang, Hong Li
Journal: Poult Sci
PubMed ID: 37939591
Doi: 10.1016/j.psj.2023.103200
Clinical Course, Immunogenicity, and Efficacy of BNT162b2 mRNA Vaccination Against SARS-CoV-2 Infection in Liver Transplant Recipients
Authors: Eunice X Tan, Wen Hui Lim, Elizabeth Thong, Jean-Marc Chavatte, Jinyan Zhang, Jonathan Lim, Jocelyn Y Jin, Daniel R X Lim, Jaclyn Y T Kang, Ansel Shao Pin Tang, Kai En Chan, Caitlyn Tan, Shi Ni Tan, Benjamin Nah, Daniel Q Huang, Lin-Fa Wang, Paul A Tambyah, Jyoti Somani, Barnaby Young, Mark D Muthiah
Journal: Transplant Direct
PubMed ID: 37745946
Doi: 10.1097/TXD.0000000000001537
Ligand-displaying cells and minicells for programmable delivery of toxic payloads via type IV secretion systems
Authors: Yang Grace Li, Kouhei Kishida, Natsumi Ogawa-Kishida, Peter J Christie
Journal: MBio
PubMed ID: 37772866
Doi: 10.1128/mbio.02143-23
Characterization of nanodisc-forming peptides for membrane protein studies
Authors: Bankala Krishnarjuna, Gaurav Sharma, Sang-Choul Im, Richard Auchus, G M Anantharamaiah, Ayyalusamy Ramamoorthy
Journal: J Colloid Interface Sci
PubMed ID: 37801850
Doi: 10.1016/j.jcis.2023.09.162

喜欢新升级的网站吗?

讨厌

不喜欢

一般

喜欢

非常喜欢

*